Volume 13, Number 4—April 2007
Synopsis
Human Benefits of Animal Interventions for Zoonosis Control
Table 1
Cost | Benefit | Net present value‡ | Benefit: cost ratio§ | |
Total agriculture sector | 5,174.9 | 16,611.6 | 11,436.7 | 3.2 |
Human health | ||||
Public health sector | ||||
Central government | 1,009.4 | 3,240.3 | 2,230.9 | 3.2 |
Health Insurance Fund | 0.0 | 0.0 | 0.0 | |
Patient | ||||
Out-of-pocket contribution to health costs | 1,669.3 | 5,358.7 | 3,689.4 | 3.2 |
Change in household income | 1,103.7 | 3,542.8 | 2,439.1 | 3.2 |
Total overall human health | 3,782.4 | 12,141.8 | 8,359.4 | 3.2 |
Total private sector | 7,947.9 | 25,513.1 | 17,565.2 | 3.2 |
Total society | 8,957.3 | 28,753.4 | 19,796.1 | 3.2 |
*Scenario for proportion of protected animals at 52% and discount rate at 5%. Costs are in Mongolian tugriks; 1 US$ ≈1,080 MNT in October 2000.
†Table reproduced from (4).
‡Benefits minus costs.
§Benefits divided by costs (minimum 2.27, maximum 4.37).
References
- Smith NH, Gordon SV, Rua-Domenech R, Clifton-Hadley RS, Hewinson RG. Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis. Nat Rev Microbiol. 2006;4:670–81. DOIPubMedGoogle Scholar
- Bonfoh B, Wasem A, Traoré AN, Fan é A, Spillmann H, Simbé CF, et al. Microbiological quality of cows’ milk taken at different intervals from the udder to the selling point in Bamako (Mali). Food Contr. 2003;14:495–500. DOIGoogle Scholar
- Steinmann P, Bonfoh B, Peter O, Schelling E, Traore M, Zinsstag J. Seroprevalence of Q-fever in febrile individuals in Mali. Trop Med Int Health. 2005;10:612–7. DOIPubMedGoogle Scholar
- Roth F, Zinsstag J, Orkhon D, Chimed-Ochir G, Hutton G, Cosivi O, Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ. 2003;81:867–76.PubMedGoogle Scholar
- Klempner MS, Shapiro DS. Crossing the species barrier—one small step to man, one giant leap to mankind. N Engl J Med. 2004;350:1171–2. DOIPubMedGoogle Scholar
- Zinsstag J, Schelling E, Wyss K, Bechir M. Potential of cooperation between human and animal health to strengthen health systems. Lancet. 2005;366:2142–5. DOIPubMedGoogle Scholar
- Osofsky SA, Cleaveland S, Karesh WB, Kock MD, Nyhus PJ, Starr L, Conservation and development interventions at the wildlife/livestock interface: implications for wildlife, livestock and human health. Gland (Switzerland) and Cambridge (UK): The World Conservation Union; 2005.
- Cook RA, Karesh WB, Osofsky SA. Building interdisciplinary bridges to health in a globalized world. Presented at One World One Health Symposium, 2004 Sep 29; New York. [cited 2007 Feb 14]. Available from http://www.oneworldonehealth.org/sept2004/owoh_sept04.html.
- Lundervold M, Milner-Gulland EJ, O'Callaghan CJ, Hamblin C, Corteyn A, Macmillan AP. A serological survey of ruminant livestock in Kazakhstan during post-Soviet transitions in farming and disease control. Acta Vet Scand. 2004;45:211–24. DOIPubMedGoogle Scholar
- Zinsstag J, Roth F, Orkhon D, Chimed-Ochir G, Nansalmaa M, Kolar J, A model of animal-human brucellosis transmission in Mongolia. Prev Vet Med. 2005;69:77–95. DOIPubMedGoogle Scholar
- Madkour AA. Madkour’s brucellosis. Berlin: Springer Verlag; 2001.
- Warrell DA, Warrell MJ. Human rabies: a continuing challenge in the tropical world. Schweiz Med Wochenschr. 1995;125:879–85.PubMedGoogle Scholar
- Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, Miranda ME, Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005;83:360–8.PubMedGoogle Scholar
- Wandeler AI, Matter HC, Kappeler A, Budde A. The ecology of dogs and canine rabies: a selective review. Rev Sci Tech. 1993;12:51–71.PubMedGoogle Scholar
- Bögel K, Meslin FX. Economics of human and canine rabies elimination: guidelines for programme orientation. Bull World Health Organ. 1990;68:281–91.PubMedGoogle Scholar
- Kayali U, Mindekem R, Yemadji N, Vounatsou P, Kaninga Y, Ndoutamia AG, Coverage of pilot parenteral vaccination campaign against canine rabies in N’Djaména, Chad. Bull World Health Organ. 2003;81:739–44.PubMedGoogle Scholar
- Kayali U, Mindekem R, Hutton G, Ndoutamia AG, Zinsstag J. Cost-description of a pilot parenteral vaccination campaign against rabies in dogs in N’Djaména, Chad. Trop Med Int Health. 2006;11:1058–65. DOIPubMedGoogle Scholar
- Cleaveland S, Fevre EM, Kaare M, Coleman PG. Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bull World Health Organ. 2002;80:304–10.PubMedGoogle Scholar
- Gensheimer KF, Meltzer MI, Postema AS, Strikas RA. Influenza pandemic preparedness. Emerg Infect Dis. 2003;9:1645–8.PubMedGoogle Scholar
- Digoutte JP. Present status of an arbovirus infection: yellow fever, its natural history of hemorrhagic fever, Rift Valley fever [in French]. Bull Soc Pathol Exot. 1999;92:343–8.PubMedGoogle Scholar
- Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich SS, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006;3:e102. DOIPubMedGoogle Scholar
- Utzinger J, de Savigny D. Control of neglected tropical diseases: integrated chemotherapy and beyond. PLoS Med. 2006;3:e112. DOIPubMedGoogle Scholar
- Mfinanga SG, Morkve O, Kazwala RR, Cleaveland S, Sharp JM, Shirima G, The role of livestock keeping in tuberculosis trends in Arusha, Tanzania. Int J Tuberc Lung Dis. 2003;7:695–704.PubMedGoogle Scholar
- International Pledging Conference on Avian and Human Pandemic Influenza; 2006 Jan 17–18; Beijing.
- Murray CJL, Lopez AD, eds. Global comparative assessments in the health sector: disease burden, expenditures and interventions packages. Geneva: World Health Organization; 1994.
- Benenson AS. Control of communicable diseases in man. Washington (DC): American Public Health Association; 1985.
- Gsell O, Mohr W, eds. Infectious diseases [in German]. Berlin: Springer Verlag; 1968.
Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.